Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Detection of elevated antibodies against SR protein kinase 1 in the serum of Alzheimer's disease patients.

Daniilidou M, Tsolaki M, Giannakouros T, Nikolakaki E.

J Neuroimmunol. 2011 Sep 15;238(1-2):67-72. doi: 10.1016/j.jneuroim.2011.06.013. Epub 2011 Jul 27.

PMID:
21794928
2.

Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients.

Moir RD, Tseitlin KA, Soscia S, Hyman BT, Irizarry MC, Tanzi RE.

J Biol Chem. 2005 Apr 29;280(17):17458-63. Epub 2005 Feb 21.

3.

Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals.

Weksler ME, Relkin N, Turkenich R, LaRusse S, Zhou L, Szabo P.

Exp Gerontol. 2002 Jul;37(7):943-8.

PMID:
12086704
4.

Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease.

Kankaanpää J, Turunen SP, Moilanen V, Hörkkö S, Remes AM.

Neurobiol Dis. 2009 Mar;33(3):467-72. doi: 10.1016/j.nbd.2008.12.001. Epub 2008 Dec 16.

PMID:
19130885
5.

Enzyme-linked immunosorbent assay for human autoantibody to glial fibrillary acidic protein: higher titer of the antibody is detected in serum of patients with Alzheimer's disease.

Tanaka J, Nakamura K, Takeda M, Tada K, Suzuki H, Morita H, Okado T, Hariguchi S, Nishimura T.

Acta Neurol Scand. 1989 Dec;80(6):554-60.

PMID:
2618583
6.

Increased acidic fibroblast growth factor concentrations in the serum and cerebrospinal fluid of patients with Alzheimer's disease.

Mashayekhi F, Hadavi M, Vaziri HR, Naji M.

J Clin Neurosci. 2010 Mar;17(3):357-9. doi: 10.1016/j.jocn.2009.05.037. Epub 2010 Jan 15.

PMID:
20079650
7.

A relationship between Alzheimer's disease and type 2 diabetes mellitus through the measurement of serum amyloid-beta autoantibodies.

Kim I, Lee J, Hong HJ, Jung ES, Ku YH, Jeong IK, Cho YM, So I, Park KS, Mook-Jung I.

J Alzheimers Dis. 2010;19(4):1371-6. doi: 10.3233/JAD-2010-1332.

PMID:
20061608
9.

Antibodies to viral antigens, xenoantigens, and autoantigens in Alzheimer's disease.

Ounanian A, Guilbert B, Renversez JC, Seigneurin JM, Avrameas S.

J Clin Lab Anal. 1990;4(5):367-75.

PMID:
2172499
10.

Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer's disease and control subjects.

Baril L, Nicolas L, Croisile B, Crozier P, Hessler C, Sassolas A, McCormick JB, Trannoy E.

Neurosci Lett. 2004 Jan 30;355(3):226-30.

PMID:
14732472
11.

SR protein-specific kinase 1 is highly expressed in testis and phosphorylates protamine 1.

Papoutsopoulou S, Nikolakaki E, Chalepakis G, Kruft V, Chevaillier P, Giannakouros T.

Nucleic Acids Res. 1999 Jul 15;27(14):2972-80.

12.

Redox-reactive antiphospholipid antibody differences between serum from Alzheimer's patients and age-matched controls.

McIntyre JA, Wagenknecht DR, Ramsey CJ.

Autoimmunity. 2009;42(8):646-52. doi: 10.3109/08916930903074833.

PMID:
19886736
13.

Glial fibrillary acidic protein stimulates proliferation and immunoglobulin synthesis of lymphocytes from Alzheimer's disease patients.

Nakamura K, Takeda M, Tanaka T, Tanaka J, Kato Y, Nishinuma K, Nishimura T.

Methods Find Exp Clin Pharmacol. 1992 Mar;14(2):141-9.

PMID:
1598026
15.

SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.

Colwill K, Feng LL, Yeakley JM, Gish GD, Cáceres JF, Pawson T, Fu XD.

J Biol Chem. 1996 Oct 4;271(40):24569-75.

16.

Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.

Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H, Lehnert S, Kretzschmar HA, Baier M, Otto M.

J Alzheimers Dis. 2009;17(3):541-51. doi: 10.3233/JAD-2009-1075.

PMID:
19433893
17.

BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.

Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A, Soekadar S, Richartz E, Koehler N, Bartels M, Buchkremer G, Schott K.

J Psychiatr Res. 2007 Aug;41(5):387-94. Epub 2006 Mar 22.

PMID:
16554070
18.

Increased midkine levels in sera from patients with Alzheimer's disease.

Salama RH, Muramatsu H, Shimizu E, Hashimoto K, Ohgake S, Watanabe H, Komatsu N, Okamura N, Koike K, Shinoda N, Okada S, Iyo M, Muramatsu T.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29(4):611-6.

PMID:
15866365
19.

Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

Diamandis EP, Scorilas A, Kishi T, Blennow K, Luo LY, Soosaipillai A, Rademaker AW, Sjogren M.

Clin Biochem. 2004 Mar;37(3):230-7.

PMID:
14972646
20.

Supplemental Content

Support Center